Safety and Efficacy of Bedaquiline in Drug Resistant Tuberculosis: A Hospital-based Prospective Observational Study

QR Code

Safety and Efficacy of Bedaquiline in Drug Resistant Tuberculosis: A Hospital-based Prospective Observational Study

Introduction: Tuberculosis (TB) is a chronic infectious disease that continues to cause significant morbidity and mortality in developing nations. The emergence of Drug Resistant Tuberculosis (DR-TB) has further aggravated the problem. The treatment of DR-TB is challenging due to poor compliance, st...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saima Ejaz, Imrana Masood, Md Mokarram Ali, Ummul Baneen, Zuber Ahmad, Rakesh Bhargava
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2025-06-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	adverse drug reaction antitubercular agents multidrug-resistant tuberculosis
Online Access:	https://jcdr.net/articles/PDF/21129/74406_CE[Ra1]_F(SL)_QC(AN_SS)_PF1(AG_KR)_PFA(IS)_PB(AG_IS)_PN(IS).pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tuberculosis: The implications for anaesthesia
by: T.A. Jackson, et al.
Published: (2014-11-01)

Tuberculosis: The implications for anaesthesia
by: T.A. Jackson, et al.
Published: (2014-05-01)

Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01)

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis
by: Sagarika N. Suresh, et al.
Published: (2025-01-01)

Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01)

Treatment outcomes of bedaquiline-based longer oral antitubercular regimens in Indian children above five years of age
by: Ira Shah, et al.
Published: (2025-07-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Social aspects multi-drug resistant tuberculosis
by: O. V. Filinyuk, et al.
Published: (2012-08-01)

Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs
by: A. S. Shalmin, et al.
Published: (2015-08-01)

Knowledge, Attitude, and Practice Toward Antitubercular Agents Among Pulmonary Tuberculosis Patients in Southwestern China: A Cross-Sectional Study
by: Pi Y, et al.
Published: (2025-05-01)

Multi-Drug Resistance of Mycobacterium Tuberculosis – the Problem of Modern Phthisiology
by: E. Yu. Zorkaltseva, et al.
Published: (2019-05-01)

Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis
by: Haiyan Chen, et al.
Published: (2025-07-01)

EFFECTIVE MANAGEMENT OF PULMONARY TUBERCULOSIS COMPLICATED WITH MYCOBACTERIAL DRUG RESISTANCE IN THE REPUBLIC OF BURYATIA
by: S. V. Nikolayeva
Published: (2012-09-01)

Evaluation of Epidemiological Manifestations of Tuberculosis and Genetic Diversity of Mycobacterium tuberculosis Strains with Multiple Drug Resistance in the Omsk Region
by: I. V. Kostyukova, et al.
Published: (2025-05-01)

Resurgence of multidrug-resistant tuberculosis during the COVID-19 pandemic in Korea
by: Tae Hoon Kim, et al.
Published: (2025-06-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

CHARACTERISTIC OF MULTIDRAG RESISTANCE IN TUBERKULOSIS PATIENTS IN SEPARATE TERRITORIES OF IRKUTSK REGION
by: O. A. Vorobyova, et al.
Published: (2016-11-01)

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT
by: N. M. Koretskaya, et al.
Published: (2012-09-01)

Drug resistance patterns, trends, and risk factors for multidrug resistance of tuberculosis in Wenzhou, China: a ten-year retrospective analysis (2014–2023)
by: Lianpeng Wu, et al.
Published: (2025-07-01)

Resistance Rates of <i>Mycobacterium tuberculosis</i> Complex Strains: A Retrospective Study in Türkiye
by: Melda Payaslıoğlu, et al.
Published: (2025-06-01)

Identification of Datura innoxia as a potential source of antimycobacterial components
by: Sajjad Ahmed Khan, et al.
Published: (2025-07-01)

The effectiveness and safety of complex treatment of patients with drug-resistant pulmonary tuberculosis using delamanide
by: A. M. Tikhonov, et al.
Published: (2025-05-01)

Diagnostic Modalities for Detecting Extrapulmonary Tuberculosis and Resistance Patterns of Rifampicin and Isoniazid at a Referral Hospital: A Retro Prospective Study
by: Ankur Kumar, et al.
Published: (2025-04-01)

Multidrug-resistant pulmonary tuberculosis in Esmeraldas, Ecuador (2018–2022): prevalence and clinical–epidemiological profile from a retrospective observational study
by: Jaime Angamarca-Iguago
Published: (2025-07-01)

Characteristics of new cases of infiltrative pulmonary tuberculosis in patients having HIV infection with multidrug resistance of the pathogen according to multi-layer spiral computed tomography
by: Yu. V. Bazhenova, et al.
Published: (2023-10-01)

Investigation of the Safety of Radiopaque Compounds Based on Notification Cards on Adverse Reactions Registered in the Republic of Crimea
by: A. V. Matveev, et al.
Published: (2021-01-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysis
by: A. V. Kukurika
Published: (2025-03-01)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

Multimodal radiomics integrating deep learning and clinical features for diagnosing multidrug-resistant tuberculosis in HIV/AIDS patients
by: Chang Song, et al.
Published: (2025-06-01)

The Usefulness of the BD MAX MDR-TB Molecular Test in the Rapid Diagnosis of Multidrug-Resistant Tuberculosis
by: Tomasz Bogiel, et al.
Published: (2025-06-01)

Ligand-based discovery of novel N-arylpyrrole derivatives as broad-spectrum antimicrobial agents with antibiofilm and anti-virulence activity
by: Basma M. Qandeel, et al.
Published: (2025-12-01)

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01)

Spatial clusters of risk and cartography of care for drug-resistant tuberculosis
by: Jaqueline Garcia de Almeida Ballestero, et al.
Published: (2025-06-01)

Clinico-Microbiological Profile of Infections in the Surgical Intensive Care Unit : An Observational Prospective Study
by: Amarpreet Kaur, et al.
Published: (2025-07-01)

Mixed infections and heteroresistance of Mycobacterium tuberculosis among multidrug-resistant tuberculosis in China: a genomic epidemiology study
by: Yanping Liu, et al.
Published: (2025-12-01)